The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
Read moreJohn Hopkins Center for Psychedelic and Consciousness Research
Check out the articles and projects at the John Hopkins Center for Psychedelic and Consciousness Research.
Read moreThe Potential of Psychedelics
Dr. Hayes is an anesthesiologist at Empire Anesthesia, which focuses on palliative and end-of-life care. In this interview, she discusses psychedelics’ potential to help people awaken to their power.
Read morePsilocybin Research Update
Keep reading for an in-depth update on psilocybin research.
Read moreAyahuasca and Dreaming
In a new study published in Scientific Reports, researchers show that ayahuasca alters the user's waking brain-wave patterns to produce a mental state that the researchers describe as "dreaming while awake."
Read moreA Personal Accountant of Ayahuasca and Depression
Keep reading for an anthropologist’s account of how ayahuasca helped with his depression.
Read moreHallucinogenic Therapy
This article looks at the power and promise of hallucinogenic therapy.
Read moreIntegrating Ayahuasca
When people feel worse after drinking ayahuasca, integration is essential.
Read moreResearch on DMT
Here’s a look at what the current research on DMT is showing us.
Read moreThe Extraordinary Therapeutic Potential of Psychedelic Drugs
This author spent months talking to psychedelic guides and researchers, here is what he learned.
Read moreChanging Views on Psychedelics
Psychedelic research continues to explode! Scientists are leading the way in rethinking psychedelics as attitudes change.
Read more